TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst

eLife

Volumn 4, Issue OCTOBER2015, 2015, Pages

  Hermann, Clemens ^a,e   van Hateren, Andy ^b   Trautwein, Nico ^c   Neerincx, Andreas ^a   Duriez, Patrick J ^b   Stevanović, Stefan ^c   Trowsdale, John ^a   Deane, Janet E ^d   Elliott, Tim ^b   Boyle, Louise H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN C JUN; PROTEIN FOS; TAPASIN; TAPASIN RELATED PROTEIN; UNCLASSIFIED DRUG; ANTIGEN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN; MEMBRANE PROTEIN; PEPTIDE; PROTEIN BINDING; TAPBPL PROTEIN, HUMAN;

ANTIGEN PRESENTATION; ARTICLE; DIFFERENTIAL SCANNING FLUORIMETRY; FLOW CYTOMETRY; FLUORESCENCE POLARIZATION; FLUOROMETRY; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIZE EXCLUSION CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; CELL LINE; METABOLISM;

ANTIGEN PRESENTATION; ANTIGENS; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULINS; MEMBRANE PROTEINS; PEPTIDES; PROTEIN BINDING;

EID: 84955322508     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.09617.001     Document Type: Article

References (48)

1. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. 2009. Human leucocyte antigen (hLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127:26-39. doi: 10.1111/j.1365-2567.2008.03019.x
2. Aricescu AR, Lu W, Jones EY. 2006. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallographica. Section D, Biological Crystallography 62:1243-1250. doi: 10.1107/ S0907444906029799/gx5088sup1.pdf
3. Barber LD, Howarth M, Bowness P, Elliott T. 2001. The quantity of naturally processed peptides stably bound by HLA-a*0201 is significantly reduced in the absence of tapasin. Tissue Antigens 58:363-368. doi: 10.1034/j. 1399-0039.2001.580604.x
4. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A. 1978. Production of monoclonal antibodies to group a erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9-20. doi: 10.1016/0092-8674(78)90296-9
5. Boyle LH, Hermann C, Boname JM, Porter KM, Patel PA, Burr ML, Duncan LM, Harbour ME, Rhodes DA, Skjødt K, Lehner PJ, Trowsdale J. 2013. Tapasin-related protein TAPBPR is an additional component of the MHC class i presentation pathway. Proceedings of the National Academy of Sciences of the United States of America 110: 3465-3470. doi: 10.1073/pnas.1222342110
6. Chen M, Bouvier M. 2007. Analysis of interactions in a tapasin/class i complex provides a mechanism for peptide selection. The EMBO Journal 26:1681-1690. doi: 10.1038/sj.emboj.7601624
7. Dick TP, Bangia N, Peaper DR, Cresswell P. 2002. Disulfide bond isomerization and the assembly of MHC class i- peptide complexes. Immunity 16:87-98. doi: 10.1016/S1074-7613(02)00263-7
8. Dong G, Wearsch PA, Peaper DR, Cresswell P, Reinisch KM. 2009. Insights into MHC class i peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity 30:21-32. doi: 10.1016/j. immuni.2008.10.018
9. Duan F, Duitama J, Al Seesi S, Ayres CM, Corcelli SA, Pawashe AP, Blanchard T, Mcmahon D, Sidney J, Sette A, Baker BM, Mandoiu II, Srivastava PK. 2014. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. The Journal of Experimental Medicine 211:2231-2248. doi: 10.1107/S0907444904013587
10. Garboczi DN, Hung DT, Wiley DC. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in escherichia coli and complexed with single antigenic peptides. Proceedings of the National Academy of Sciences of the United States of America 89:3429-3433. doi: 10.1073/pnas.89.8.3429
11. Greenwood R, Shimizu Y, Sekhon GS, Demars R. 1994. Novel allele-specific, post-translational reduction in HLA class i surface expression in a mutant human b cell line. Journal of Immunology 153:5525-5536.
12. Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber W-J, Mulder GE, Toebes M, Vesely MD, Lam SSK, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee H-G, Melief CJM, Mardis ER, Gillanders WE, Artyomov MN Schreiber RD. 2014. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515:577-581. doi: 10.1038/nature13988
13. Hermann C, Strittmatter LM, Deane JE, Boyle LH. 2013. The binding of TAPBPR and tapasin to MHC class i is mutually exclusive. Journal of Immunology 191:5743-5750. doi: 10.4049/jimmunol.1300929
14. Hermann C, Trowsdale J, Boyle LH. 2015. TAPBPR: a new player in the MHC class i presentation pathway. Tissue Antigens 85:155-166. doi: 10.1111/tan.12538
15. Howarth M, Williams A, Tolstrup AB, Elliott T. 2004. Tapasin enhances MHC class i peptide presentation according to peptide half-life. Proceedings of the National Academy of Sciences of the United States of America 101:11737-11742. doi: 10.1073/pnas.0306294101
16. Kanaseki T, Lind KC, Escobar H, Nagarajan N, Reyes-Vargas E, Rudd B, Rockwood AL, van Kaer L, Sato N, Delgado JC, Shastri N. 2013. ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class i peptides. Journal of Immunology 191:1547-1555. doi: 10.4049/jimmunol.1301043
17. Lehner PJ, Surman MJ, Cresswell P. 1998. Soluble tapasin restores MHC class i expression and function in the tapasin-negative cell line .220. Immunity 8:221-231. doi: 10.1016/S1074-7613(00)80474-4
18. Lewis JW, Neisig A, Neefjes J, Elliott T. 1996. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Current Biology 6:873-883. doi: 10.1016/S0960-9822(02)00611-5
19. Lewis JW, Sewell A, Price D, Elliott T. 1998. HLA-a*0201 presents TAP-dependent peptide epitopes to cytotoxic t lymphocytes in the absence of tapasin. European Journal of Immunology 28:3214-3220. doi: 10.1002/(SICI) 1521-4141(199810)28:10<3214::AID-IMMU3214>3.0.CO;2-C
20. Li S, Sjogren H-O, Hellman U, Pettersson RF, Wang P, Sjogren HO, Hellman U, Pettersson RF, Wang P. 1997. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proceedings of the National Academy of Sciences 94:8708-8713. doi: 10.1073/pnas.94.16.8708
21. Lundegaard C, Lamberth K, Harndahl M, Buus Søren, Lund O, Nielsen M. 2008a. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class i affinities for peptides of length 8-11. Nucleic Acids Research 36:W509-W512. doi: 10.1093/nar/gkn202
22. Lundegaard C, Lund O, Nielsen M. 2008b. Accurate approximation method for prediction of class i MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 24:1397-1398. doi: 10.1093/bioinformatics/btn128
23. Lutz PM, Cresswell P. 1987. An epitope common to HLA class i and class II antigens, ig light chains, and beta 2- microglobulin. Immunogenetics 25:228-233. doi: 10.1007/BF00404692
24. Momburg F, Tan P. 2002. Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class i molecules in the endoplasmic reticulum. Molecular Immunology 39:217-233. doi: 10.1016/S0161-5890 (02)00103-7
25. Niesen FH, Berglund H, Vedadi M. 2007. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nature Protocols 2:2212-2221. doi: 10.1038/nprot.2007.321
26. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, Riddell SR, TampéR, Spies T, Trowsdale J, Cresswell P. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class i-TAP complexes. Science 277:1306-1309. doi: 10.1126/science.277.5330.1306
27. Peace-Brewer AL, Tussey LG, Matsui M, Li G, Quinn DG, Frelinger JA. 1996. A point mutation in HLA-a*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4:505-514. doi: 10.1016/S1074-7613(00)80416-1
28. Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, McCluskey J. 1998. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class i peptide loading. Immunity 8:531-542. doi: 10.1016/S1074-7613(00)80558-0
29. Perosa F, Luccarelli G, Prete M, Favoino E, Ferrone S, Dammacco F. 2003. Beta 2-microglobulin-free HLA class i heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. Journal of Immunology 171: 1918-1926. doi: 10.4049/jimmunol.171.4.1918
30. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. 2013. Genome engineering using the CRISPR-Cas9 system. Nature Protocols 8:2281-2308. doi: 10.1038/nprot.2013.143
31. Rebaï N, Malissen B. 1983. Structural and genetic analyses of HLA class i molecules using monoclonal xenoantibodies. Tissue Antigens 22:107-117. doi: 10.1111/j.1399-0039.1983.tb01176.x
32. Rizvi SM, Salam N, Geng J, Qi Y, Bream JH, Duggal P, Hussain SK, Martinson J, Wolinsky SM, Carrington M, Raghavan M. 2014. Distinct assembly profiles of HLA-b molecules. Journal of Immunology 192:4967-4976. doi: 10.4049/jimmunol.1301670
33. Rötzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee HG. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic t cells. Nature 348:252-254. doi: 10. 1038/348252a0
34. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class i molecules with TAP. Immunity 5:103-114. doi: 10.1016/S1074-7613 (00)80487-2
35. Sernee MF, Ploegh HL, Schust DJ. 1998. Why certain antibodies cross-react with HLA- a and HLA-g: epitope mapping of two common MHC class i reagents. Molecular Immunology 35:177-188. doi: 10.1016/S0161-5890 (98)00026-1
36. Sewell AK. 2012. Why must t cells be cross-reactive? Nature Reviews. Immunology 12:669-677. doi: 10.1038/ nri3279
37. Shimizu Y, Geraghty DE, Koller BH, Orr HT, Demars R. 1988. Transfer and expression of three cloned human non-HLA-a,b,c class i major histocompatibility complex genes in mutant lymphoblastoid cells. Proceedings of the National Academy of Sciences of the United States of America 85:227-231. doi: 10.1073/pnas.85.1.227
38. Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, Walsh LA, Postow MA, Wong P, Ho TS, Hollmann TJ, Bruggeman C, Kannan K, Li Y, Elipenahli C, Liu C, Harbison CT, Wang L, Ribas A, Wolchok JD, Chan TA. 2014. Genetic basis for clinical response to CTLA-4 blockade in melanoma. The New England Journal of Medicine 371:2189-2199. doi: 10.1056/NEJMoa1406498
39. Stam NJ, Spits H, Ploegh HL. 1986. Monoclonal antibodies raised against denatured HLA-b locus heavy chains permit biochemical characterization of certain HLA-c locus products. Journal of Immunology 137:2299-2306.
40. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL. 1990. HLA-a- and HLA-b-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. International Immunology 2:113-125. doi: 10.1093/intimm/2.2.113
41. Tan P, Kropshofer H, Mandelboim O, Bulbuc N, Hämmerling Günter J, Momburg F. 2002. Recruitment of MHC class i molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading. Journal of Immunology 168:1950-1960. doi: 10.4049/jimmunol.168.4. 1950
42. Teng MS, Stephens R, du Pasquier L, Freeman T, Lindquist JA, Trowsdale J. 2002. A human TAPBP (tAPASIN)- related gene, TAPBP-r. European Journal of Immunology 32:1059-1068. doi: 10.1002/1521-4141(200204)32: 4<1059::AID-IMMU1059>3.0.CO;2-G
43. van Hateren A, Carter R, Bailey A, Kontouli N, Williams AP, Kaufman J, Elliott T. 2013. A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class i (mHC I) proteins. The Journal of Biological Chemistry 288:32797-32808. doi: 10.1074/jbc.M113.474031
44. Wearsch PA, Cresswell P. 2007. Selective loading of high-affinity peptides onto major histocompatibility complex class i molecules by the tapasin-ERp57 heterodimer. Nature Immunology 8:873-881. doi: 10.1038/ni1485
45. Williams AP, Peh CA, Purcell AW, Mccluskey J, Elliott T. 2002. Optimization of the MHC class i peptide cargo is dependent on tapasin. Immunity 16:509-520. doi: 10.1016/S1074-7613(02)00304-7
46. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, Dolton G, Clement M, Llewellyn-Lacey S, Price DA, Peakman M, Sewell AK. 2012. A single autoimmune t cell receptor recognizes more than a million different peptides. The Journal of Biological Chemistry 287:1168-1177. doi: 10.1074/jbc. M111.289488
47. Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, Franci C, Cheung TK, Fritsche J, Weinschenk T, Modrusan Z, Mellman I, Lill JR, Delamarre Lélia. 2014. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515:572-576. doi: 10.1038/ nature14001
48. Yang SY, Morishima Y, Collins NH, Alton T, Pollack MS, Yunis EJ, Dupont B. 1984. Comparison of one- dimensional IEF patterns for serologically detectable HLA-a and b allotypes. Immunogenetics 19:217-231. doi: 10.1007/BF00364765